Gene · 7138
Papers3,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between living alone and all-cause mortality of young and middle-aged patients with acute myocardial infarction: analysis of the China Acute Myocardial Infarction (CAMI) registry. | BMC Public Health | 2024 | 38166780 | PubTator, text mining | PubMed |
| HMZDupFinder: a robust computational approach for detecting intragenic homozygous duplications from exome sequencing data. | Nucleic Acids Res | 2024 | 38153174 | PubTator, text mining | PubMed |
| Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes. | Mol Metab | 2024 | 38142971 | PubTator, text mining | PubMed |
| Generation of highly pure pluripotent stem cell-derived myogenic progenitor cells and myotubes. | Stem Cell Reports | 2024 | 38101399 | PubTator, text mining | PubMed |
| Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway. | Environ Toxicol | 2024 | 38095131 | PubTator, text mining | PubMed |
| Ventricular fibrillation/ventricular tachycardia within 72 h of VA-ECMO: incidence, outcomes, risk factors, and management. | ESC Heart Fail | 2024 | 38088144 | PubTator, text mining | PubMed |
| High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT). | Clin Chem | 2024 | 38084941 | PubTator, text mining | PubMed |
| A human embryonic limb cell atlas resolved in space and time. | Nature | 2024 | 38057666 | PubTator, text mining | PubMed |
| FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation. | Hum Mol Genet | 2024 | 37856562 | PubTator, text mining | PubMed |
| The Balance of CD8-Positive T Cells and PD-L1 Expression in the Myocardium Predicts Prognosis in Lymphocytic Fulminant Myocarditis. | Cardiology | 2024 | 37827123 | PubTator, text mining | PubMed |
| Cardiac MRI T1 and T2 Mapping as a Quantitative Imaging Biomarker in Transthyretin Amyloid Cardiomyopathy. | Acad Radiol | 2024 | 37775448 | PubTator, text mining | PubMed |
| Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1. | J Endocrinol Invest | 2024 | 37477865 | PubTator, text mining | PubMed |
| Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review. | Cardiovasc Drugs Ther | 2024 | 37209261 | PubTator, text mining | PubMed |
| Role of the interaction between troponin T and AMP deaminase by zinc bridge in modulating muscle contraction and ammonia production. | Mol Cell Biochem | 2024 | 37184757 | PubTator, text mining | PubMed |
| Intra-operative anesthetic induced myocardial protection during cardiothoracic surgery: a literature review. | J Thorac Dis | 2023 | 38249920 | PubTator, text mining | PubMed |
| Impact of Reperfusion on Plasma Oxylipins in ST-Segment Elevation Myocardial Infarction. | Metabolites | 2023 | 38248822 | PubTator, text mining | PubMed |
| Impact of chest pain center quality control indicators on mortality risk in ST-segment elevation myocardial infarction patients: a study based on Killip classification. | Front Cardiovasc Med | 2023 | 38235291 | PubTator, text mining | PubMed |
| Reperfusion Injury: How Can We Reduce It by Pre-, Per-, and Postconditioning. | J Clin Med | 2023 | 38202166 | PubTator, text mining | PubMed |
| Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review. | Diagnostics (Basel) | 2023 | 38201396 | PubTator, text mining | PubMed |
| The identification of a PTEN-associated gene signature for the prediction of prognosis and planning of therapeutic strategy in endometrial cancer. | Transl Cancer Res | 2023 | 38192993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7138/papers?page=10